OtherBASIC SCIENCE INVESTIGATIONS
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
Lore Santoro, Samir Boutaleb, Véronique Garambois, Caroline Bascoul-Mollevi, Vincent Boudousq, Pierre-Olivier Kotzki, Monique Pèlegrin, Isabelle Navarro-Teulon, André Pèlegrin and Jean-Pierre Pouget
Journal of Nuclear Medicine December 2009, 50 (12) 2033-2041; DOI: https://doi.org/10.2967/jnumed.109.066993
Lore Santoro
Samir Boutaleb
Véronique Garambois
Caroline Bascoul-Mollevi
Vincent Boudousq
Pierre-Olivier Kotzki
Monique Pèlegrin
Isabelle Navarro-Teulon
André Pèlegrin

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 50, Issue 12
December 2009
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
Lore Santoro, Samir Boutaleb, Véronique Garambois, Caroline Bascoul-Mollevi, Vincent Boudousq, Pierre-Olivier Kotzki, Monique Pèlegrin, Isabelle Navarro-Teulon, André Pèlegrin, Jean-Pierre Pouget
Journal of Nuclear Medicine Dec 2009, 50 (12) 2033-2041; DOI: 10.2967/jnumed.109.066993
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
Lore Santoro, Samir Boutaleb, Véronique Garambois, Caroline Bascoul-Mollevi, Vincent Boudousq, Pierre-Olivier Kotzki, Monique Pèlegrin, Isabelle Navarro-Teulon, André Pèlegrin, Jean-Pierre Pouget
Journal of Nuclear Medicine Dec 2009, 50 (12) 2033-2041; DOI: 10.2967/jnumed.109.066993
Jump to section
Related Articles
Cited By...
- Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy
- Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy
- Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
- Radiolabeled Antibodies Against Mullerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
- Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
- Molecular Radiotherapy Using Cleavable Radioimmunoconjugates That Target EGFR and {gamma}H2AX
- Experimental Radionuclide Therapy of HER2-Expressing Xenografts Using Two-Step Targeting Nuclisome Particles
- Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
- Brief Intraperitoneal Radioimmunotherapy of Small Peritoneal Carcinomatosis Using High Activities of Noninternalizing 125I-Labeled Monoclonal Antibodies